AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca lands three major wins at Healthcare Asia Medtech Awards 2024
It won the Hospital Partnership of the Year - Singapore, Patient Advocacy Program of the Year - Singapore, and the Sustainability Initiative of the Year - Singapore titles.
AstraZeneca lands three major wins at Healthcare Asia Medtech Awards 2024
It won the Hospital Partnership of the Year - Singapore, Patient Advocacy Program of the Year - Singapore, and the Sustainability Initiative of the Year - Singapore titles.
SG acquires AstraZeneca's Evusheld
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
AstraZeneca SG signs MOU with tech partners
The partnerships aim to improve care delivery and patient outcomes.
Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Apr
09
Event News
Event News
Highlight your innovative medical initiatives at Healthcare Asia Awards, Medtech Awards, Pharma Awards 2025Â
![Highlight your innovative medical initiatives at Healthcare Asia Awards, Medtech Awards, Pharma Awards 2025Â]()
Co-Written / Partner
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
Videos
Partner Sites
Awards
Apr
10
Events
Apr
09